Bone density among infants of gestational diabetic mothers and macrosomic neonates

Irit Schushan-Eisen1, Mor Cohen, Leah Leibovitch

  • 1Department of Neonatology, The Edmond and Lili Safra Children's Hospital, Sheba Medical Center, Tel Hashomer, 52621, Ramat Gan, Israel.

Insights

Neonatal bone density is lower in macrosomic infants, not infants of diabetic mothers. Birth weight is the primary predictor of reduced bone density in newborns, suggesting reduced fetal movement impacts bone development.

Area of Science:

  • Neonatology
  • Pediatric Endocrinology
  • Orthopedics

Background:

  • Decreased bone density is observed in infants of diabetic mothers and large-for-gestational-age newborns.
  • The specific etiological factors (physical vs. metabolic) influencing neonatal bone density require clarification.

Purpose of the Study:

  • To determine whether physical or metabolic effects have a greater impact on neonatal bone density.
  • To compare bone density in appropriate-for-gestational-age infants of gestational diabetic mothers (IGDM) and macrosomic infants.

Main Methods:

  • A case-control study involving 20 appropriate-for-gestational-age infants of gestational diabetic mothers (IGDM) and their matched controls.
  • A second group comprised 20 macrosomic infants (birth weight > 4 kg) and their matched controls.
  • Quantitative ultrasound of the tibia was used to measure bone density (speed of sound).

Main Results:

  • Macrosomic infants exhibited significantly lower bone density compared to controls (2,976 vs. 3,120 m/s, p < 0.005).
  • No significant difference in bone density was found between IGDM infants and their controls (3,005 vs. 3,043 m/s, p = 0.286).
  • Higher birth weight was the sole predictor of low bone density (OR 1.148 per 100g increase, p = 0.003).

Conclusions:

  • Neonatal bone density is reduced in macrosomic infants, but not in appropriate-for-gestational-age infants of diabetic mothers.
  • These findings support the hypothesis that reduced fetal movement, secondary to fetal macrosomia, is the mechanism for decreased bone density.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.8K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
7.9K
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
17
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
12